Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ravidasvir Combination Therapy for Chronic Hepatitis C
NCT01859962Phase 2Completed
- Sponsor
- Presidio Pharmaceuticals
- Start
- May 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ravidasvir in hepatitis C (HCV), sponsored by Presidio Pharmaceuticals. Started May 2013; status: completed.
02
Drugs
ravidasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01859962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01859962.